Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inogen, Inc - Common Stock (NQ:INGN)

7.950 +0.240 (+3.11%)
Streaming Delayed Price Updated: 2:38 PM EDT, Aug 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Inogen, Inc - Common Stock

< Previous 1 2 3 Next >
Inogen Announces Second Quarter 2025 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025
From Inogen, Inc.
Via Business Wire
Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy
From Inogen, Inc.
Via Business Wire
Inogen Announces First Quarter 2025 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025
From Inogen, Inc.
Via Business Wire
Inogen To Present at 24th Annual Needham Virtual Healthcare Conference
From Inogen, Inc.
Via Business Wire
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West
From Inogen, Inc.
Via Business Wire
Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell
From Inogen, Inc.
Via Business Wire
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
From Inogen, Inc.
Via Business Wire
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
From Inogen, Inc.
Via Business Wire
Inogen Announces Third Quarter 2024 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Present at Upcoming Investor Conferences
From Inogen, Inc.
Via Business Wire
Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024
From Inogen, Inc.
Via Business Wire
Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC
From Inogen, Inc.
Via Business Wire
Inogen Appoints Eric Pauls as Vice President of Sales, North America
From Inogen, Inc.
Via Business Wire
Inogen Announces Second Quarter 2024 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024
From Inogen, Inc.
Via Business Wire
Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development
From Inogen, Inc.
Via Business Wire
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
From Inogen, Inc.
Via Business Wire
Inogen Announces First Quarter 2024 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
From Inogen, Inc.
Via Business Wire
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
From Inogen, Inc.
Via Business Wire
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Inogen, Inc.
Via Business Wire
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results
From Inogen, Inc.
Via Business Wire
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
From Inogen, Inc.
Via Business Wire
Inogen Names Michael Bourque as New Chief Financial Officer
From Inogen, Inc.
Via Business Wire
Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO
From Inogen, Inc.
Via Business Wire
Inogen to Present at Upcoming Investor Conferences in November 2023
From Inogen, Inc.
Via Business Wire
Inogen Announces Third Quarter 2023 Financial Results
From Inogen, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.